Neuropsicofarmacología - GIC 21/128
![Foto de Neuropsicofarmacología - GIC 21/128](/img/grupo.png)
![Foto de Universitat Pompeu Fabra](/img/noimage_org.png)
Universitat Pompeu Fabra
Barcelona, EspañaPublications in collaboration with researchers from Universitat Pompeu Fabra (6)
2024
-
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study
European Neuropsychopharmacology, Vol. 85, pp. 66-77
-
G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits
Nature communications, Vol. 15, Núm. 1, pp. 4307
-
High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls
Psychiatry Research, Vol. 337
2023
-
Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism
Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350
2022
-
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478
2005
-
κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice
European Journal of Neuroscience, Vol. 22, Núm. 8, pp. 2106-2110